Document:

Joinder and Amendment to Series E Preferred Stock Purchase Agreement

 Exhibit 10.1 
 Execution Version 
 JOINDER AND AMENDMENT
TO 
 SERIES E PREFERRED STOCK PURCHASE AGREEMENT 
 THIS JOINDER AND AMENDMENT TO SERIES E PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is
made and entered into this 12th day of March, 2010 by and
among The Princeton Review, Inc., a Delaware corporation (the “Company”), the investors set forth on the signature pages hereto as “New Investors” (the “New Investors”), and the investors set
forth on the signature pages hereto as the “Existing Investors” (the “Existing Investors”). Terms used and not otherwise defined herein shall have the meanings set forth in the Series E Preferred Stock Purchase
Agreement by and among the Company and the Existing Investors, dated as of December 7, 2009 (the “Series E Purchase Agreement”). 
 RECITALS 
 WHEREAS, the Company and the Existing Investors entered into the
Series E Purchase Agreement, providing for the purchase and sale of 94,000 shares of the Company’s Series E Non-Convertible Preferred Stock, par value $0.01 per share (the “Series E Preferred Stock”); 
 WHEREAS, the Existing Investors constitute the holders of at least eighty-five percent (85%) of the New Preferred Stock, as required
for amendment or waiver of the Series E Purchase Agreement pursuant to Section 13.1 thereof (the “Required Holders”); and 
 WHEREAS, the Company and the Existing Investors desire to amend certain provisions of the Series E Purchase Agreement to, among other things, provide for the purchase by the New Investors at an Additional
Closing (as defined in the Series E Purchase Agreement as amended hereby) of an aggregate of 10,000 additional shares of Series E Preferred Stock and join the New Investors thereto. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the
foregoing and the mutual representations, warranties and covenants herein contained, the parties hereto, intending to be legally bound, hereby agree as follows: 
 1. Amendments to the Series E Purchase Agreement. Pursuant to Section 13.1 thereof, the Series E Purchase Agreement is hereby amended as follows: 
 1.1. Section 1. The number “98,275” shall be deleted and replaced with “108,275”. 
 1.2. Section 3. Section 3.1 shall be amended and restated as follows: 
 “3.1 Closings. 

 (a) The initial closing (the “Closing”) with respect
to the transaction contemplated in Section 2 hereof shall take place at the offices of Ropes & Gray LLP, One International Place, Boston, Massachusetts simultaneously with the closing of the Acquisition, or at such other
time and place as the Company and Purchasers may agree (the “Closing Date”). At the Closing, the Company shall deliver to each Purchaser certificates representing the Series E Preferred Stock which such Purchaser is
purchasing at the Closing as set forth on Schedule I attached hereto, registered in the name of such Purchaser, against delivery to the Company by such Purchaser of a wire transfer and/or shares of Series C Preferred Stock (as the case may
be) in the amount of the Purchase Price therefor. 
 (b) Following the Closing, an additional closing (the
“Additional Closing”) with respect to the transaction contemplated in Section 2 hereof shall take place at such other time and place as the Company and Purchasers may agree, but in no event shall such Additional
Closing occur after March 31, 2010 (the “Additional Closing Date”). At the Additional Closing, the Company shall deliver to each Purchaser certificates representing the Series E Preferred Stock which such Purchaser is
purchasing at the Additional Closing as set forth on Schedule I attached hereto (the Additional Shares”), registered in the name of such Purchaser, against delivery to the Company by such Purchaser of a wire transfer in the
amount of the Purchase Price therefor.” 
 1.3. Section 7.9. The following shall be added after the fourth
sentence of Section 7.9: 
 “In the event that an Affiliate of Camden Partners Strategic Fund IV, L.P. and Camden
Partners Strategic Fund IV-A, L.P. (together, “Camden”) is not a member of, or an observer to, the Board, and so long as Camden and its Affiliates collectively own at least twenty percent (20%) of the aggregate number of
shares of New Preferred Stock originally purchased by them hereunder, the Company covenants and agrees that it will provide to Camden the privilege to appoint one (1) observer to the Board and all committees of the Board, provided that
such observer designated by Camden shall be reasonably satisfactory to the Company.” 
 1.4. Section 7.14. The
following shall be added as Section 7.14: 
 “Upon the earlier to occur of (i) conversion of all of the
Additional Shares into shares of Series D Preferred Stock pursuant to the Series E Certificate of Designation or (ii) payment to all holders of Series E Preferred Stock in connection with any Liquidation Event (as defined in the
Series E Certificate of Designation), the New Investors shall remit to the Company an aggregate of $208,219 in cash as payment for dividend shares deemed to have accrued on the Additional Shares from the Closing Date through, but not including, the

  

 - 2 - 

 
Additional Closing Date and converted into shares of Series D Preferred Stock pursuant to subsection (i) above or paid in cash or other transaction consideration pursuant to
subsection (ii) above.” 
 1.5. Section 10. The following definitions shall be added: 
 ““Additional Closing” has the meaning assigned to it in Section 3.1(b) hereof.” 
 ““Additional Closing Date” has the meaning assigned to it in Section 3.1(b) hereof.”

 ““Additional Shares” has the meaning assigned to it in Section 3.1(b) hereof.”

 1.6. Section 13.1. The first paragraph of Section 13.1 shall be amended and restated as follows: 

“Upon the approval of the Company and the written consent of the Purchasers (a) with the right to acquire at least eighty-five
percent (85%) of the Series E Preferred Stock prior to the Closing or (b) holding at least eighty-five percent (85%) of the New Preferred Stock following the Closing (the “Aggregate Holders”), (i) the
obligations of the Company and the rights of the Purchasers under this Agreement may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely), and
(ii) the Company may enter into a supplementary agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Agreement, or of any supplemental agreement or modifying in any manner
the rights and obligations hereunder or thereunder of the Purchasers and/or the Company; provided, however, that, without a Purchaser’s consent, any such amendment or waiver shall not treat such Purchaser differently from any
other Purchaser; and provided, further, that the rights granted to Camden pursuant to Section 7.9 shall not be amended or waived without the prior written consent of Camden and the rights granted to Falcon pursuant to
Section 7.9 shall not be amended or waived without the prior written consent of Falcon. The Company shall deliver copies of such consent to any Purchasers who did not execute the same.” 
 1.7. Schedule I. Schedule I shall be amended and restated as set forth on Exhibit A hereto. 
 1.8. Additional Closing. A reference in the Series E Purchase Agreement to “Closing” or “Closings” shall include
the Additional Closing. 
  

 - 3 - 

 2. Series E Purchase Agreement Joinder. Each New Investor hereby agrees, effective as
of the date hereof, to become a party to the Series E Purchase Agreement, as amended hereby, and for all purposes of the Series E Purchase Agreement the New Investors shall be included within the term “Purchasers.” Each New Investor
further confirms that the representations and warranties contained in Section 4 of the Series E Purchase Agreement are true and correct as of the date hereof with respect to such New Investor. 
 3. Conditions of Parties’ Obligations. 
 3.1. Conditions of the New Investors’ Obligations. In addition to the conditions set forth in Section 6.1 of the Series E Purchase Agreement, the effectiveness of this Agreement is
subject to the fulfillment of the following conditions. 
 (a) Joinder and Amendment to Series E Preferred
Stock Purchase Agreement. This Agreement shall have been executed and delivered by (i) the Company, (ii) the New Investors and (iii) the Required Holders. 
 (b) Joinder and Amendment to Amended and Restated Investor Rights Agreement. A Joinder and Amendment to Amended and
Restated Investor Rights Agreement shall have been executed and delivered by (i) the Company, (ii) the New Investor and (iii) the holders of shares representing at least eighty-five (85%) of the outstanding shares of Restricted
Stock (as defined therein). 
 (c) Amendment to Certificate of Designation of Series E Preferred Stock.
The Company shall have filed an Amendment to the Certificate of Designation of the Series E Preferred Stock on or prior to the date hereof providing for an increase in the authorized shares of Series E Preferred Stock to 108,275. 
 (d) Amendment to Certificate of Designation of Series D Preferred Stock. The Company shall have filed an Amendment to
the Certificate of Designation of the Series D Convertible Preferred Stock of the Company on or prior to the date hereof providing for the renunciation of certain corporate opportunities. 
 (e) Compliance Certificate. The Company shall have delivered to the New Investors a Compliance Certificate, executed
by an officer of the Company, dated as of the date hereof to the effect that (i) except as otherwise disclosed in the Disclosure Schedule, the representations and warranties of the Company contained in Section 5 of the Series E Purchase
Agreement are complete and accurate in all material respects as of the date of the Additional Closing and (ii) the Company has performed and complied in all material respects with all agreements, obligations and conditions contained in the
Series E Purchase Agreement and in this Agreement that are required to be performed or complied with on or before the Additional Closing. 
  

 - 4 - 

 4. Prior Agreement. By execution of this Agreement, the Company and the Existing
Investors executing the same, holding in the aggregate a sufficient number of shares of New Preferred Stock to amend the Series E Purchase Agreement in accordance with Section 13.1 thereof, hereby agree that the provisions set forth in the
Series E Purchase Agreement are hereby amended as set forth herein, and hereby consent in all respects to the joinder of each New Investor to the Series E Purchase Agreement as a “Purchaser.” The Series E Purchase Agreement, as amended by
this Agreement, contains the entire agreement among the parties with respect to the subject matter thereof and hereof and shall be read and construed together as a single agreement. Except to the extent amended hereby, all of the terms, provisions
and conditions of the Series E Purchase Agreement are hereby ratified and confirmed and shall remain in full force and effect as of the date specified therein. 
 5. Miscellaneous. 
 5.1. Headings. The headings of the Sections and
paragraphs of this Agreement have been inserted for convenience of reference only and do not constitute a part of this Agreement. 
 5.2. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to its conflict of law principles. 
 5.3. Counterparts; Effectiveness. This Agreement may be executed in any number of counterparts and by different parties hereto in
separate counterparts, with the same effect as if all parties had signed the same document. All such counterparts shall be deemed an original, shall be construed together and shall constitute one and the same instrument. This Agreement shall become
effective when each party hereto shall have received counterparts hereof signed by all of the other parties hereto. 
 5.4.
Severability. If any provision of this Agreement shall be found by any court of competent jurisdiction to be invalid or unenforceable, the parties hereby waive such provision to the extent that it is found to be invalid or unenforceable. Such
provision shall, to the maximum extent allowable by law, be modified by such court so that it becomes enforceable, and, as modified, shall be enforced as any other provision hereof, all the other provisions hereof continuing in full force and
effect. 
 [Remainder of Page Intentionally Left Blank] 
  

 - 5 - 

 IN WITNESS WHEREOF, the parties hereto have caused this Joinder and Amendment to Series E
Preferred Stock Purchase Agreement to be duly executed as of the day and year first above written. 
  

			
	THE COMPANY
	
	 THE PRINCETON REVIEW, INC.

		
	 By:
	 	 /s/ Stephen Richards

	 Name:
	 	Stephen Richards
	 Title:
	 	Chief Operating Officer and Chief Financial Officer

 [Signature page to Joinder and Amendment to Series E Preferred Stock Purchase Agreement] 

			
	NEW INVESTORS:
	
	CAMDEN PARTNERS STRATEGIC FUND IV, L.P.
		
	By:	 	Camden Partners Strategic IV, LLC, its general partner
	By:	 	Camden Partners Strategic Manager, LLC, its managing member
		
	By:	 	 /s/ David L. Warnock

	Name:	 	David L. Warnock
	Title:	 	Managing Member
	
	CAMDEN PARTNERS STRATEGIC FUND IV-A, L.P.
		
	By:	 	Camden Partners Strategic IV, LLC, its general partner
	By:	 	Camden Partners Strategic Manager, LLC, its managing member
		
	By:	 	 /s/ David L. Warnock

	Name:	 	David L. Warnock
	Title:	 	Managing Member

 [Signature page to
Joinder and Amendment to Series E Preferred Stock Purchase Agreement] 

			
	 EXISTING INVESTORS:

	
	 BAIN CAPITAL VENTURE FUND 2007, L.P.

		
	 By:
	 	Bain Capital Venture Partners, L.P., its general partner
	 By:
	 	Bain Capital Investors, LLC, its general partner
		
	 By:
	 	 /s/ Jeff Crisan

	 Name:
	 	Jeff Crisan
	 Title:
	 	Managing Director
	
	 BCVI-TPR INTEGRAL L.P.

		
	 By:
	 	Bain Capital Venture Investors, LLC
		
	 By:
	 	 /s/ Jeff Crisan

	 Name:
	 	Jeff Crisan
	 Title:
	 	Managing Director
	
	 BCIP VENTURE ASSOCIATES

		
	 By:
	 	Bain Capital Investors, LLC, its managing partner
	 By:
	 	Bain Capital Venture Investors, LLC, its attorney-in-fact
		
	 By:
	 	 /s/ Jeff Crisan

	 Name:
	 	Jeff Crisan
	 Title:
	 	Managing Director
	
	 BCIP VENTURE ASSOCIATES-B

		
	 By:
	 	Bain Capital Investors, LLC, its managing partner
	 By:
	 	Bain Capital Venture Investors, LLC, its attorney-in-fact
		
	 By:
	 	 /s/ Jeff Crisan

	 Name:
	 	Jeff Crisan
	 Title:
	 	Managing Director
	
	 RGIP, LLC

		
	 By:
	 	 /s/ Ann L. Milner

	 Name:
	 	Ann L. Milner
	 Title:
	 	Managing Member

 [Signature page to
Joinder and Amendment to Series E Preferred Stock Purchase Agreement] 

			
	 PRIDES CAPITAL FUND I LP

		
	 By:
	 	Prides Capital Partners, L.L.C., its general partner
		
	 By:
	 	 /s/ Kevin A. Richardson II

	 Name:
	 	Kevin A. Richardson II
	 Title:
	 	Partner

 [Signature page to Joinder
and Amendment to Series E Preferred Stock Purchase Agreement] 

			
	 FALCON STRATEGIC PARTNERS III, LP

		
	By:	 	Falcon Strategic Investments III, LP, its general partner
	By:	 	Falcon Strategic Investments GP III, LLC, its general partner
		
	 By:
	 	 /s/ Eric Rogoff

	 Name:
	 	Eric Rogoff
	 Title:
	 	Director
	
	 FALCON MEZZANINE PARTNERS II, LP

		
	By:	 	Falcon Mezzanine Investments II, LLC, its general partner
		
	By:	 	 /s/ Eric Rogoff

	Name:	 	Eric Rogoff
	 Title:
	 	Director
	
	 FMP II CO-INVESTMENT, LLC

		
	 By:
	 	 /s/ Eric Rogoff

	 Name:
	 	Eric Rogoff
	 Title:
	 	Director

 [Signature page to Joinder
and Amendment to Series E Preferred Stock Purchase Agreement] 

 EXHIBIT A 
 SCHEDULE I 
  

													
	 Purchaser
	  	Shares of Series E
Preferred Stock
Purchased at the
Closing	  	Shares of Series E
Preferred Stock
Purchased at
the
Additional Closing	  	Total
Purchase Price
	  	Consideration
	  	  	  	  	Cash	  	Shares of
Series C
Preferred
Stock
	 Bain Capital Venture Fund 2007, L.P.
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617) 516-2010
	  	31,153.5	  	—  	  	$	31,153,500	  	 	—  	  	34,615
						
	 BCVI-TPR Integral L.P.
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617) 516-2010]
	  	25,000	  	—  	  	$	25,000,000	  	$	25,000,000	  	—  
						
	 BCIP Venture Associates
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617) 516-2010
	  	4,403.7	  	—  	  	$	4,403,700	  	 	—  	  	4,893
						
	 BCIP Venture Associates-B
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617) 516-2010
	  	82.8	  	—  	  	$	82,800	  	 	—  	  	92
						
	 Prides Capital Fund I LP
 c/o Prides Capital Partners, L.L.C.
 200 High Street, Suite 700
 Boston, MA 02110
 Facsimile No: (617) 778-9299
	  	18,000	  	—  	  	$	18,000,000	  	 	—  	  	20,000
						
	 RGIP, LLC
 c/o Ropes & Gray LLP
 One International Place
 Boston, MA 02110
 Attn: Joel F. Freedman, Esq.
 Facsimile No: (617) 951-7050
	  	360	  	—  	  	$	360,000	  	 	—  	  	400
						
	 Falcon Strategic Partners III, LP
 c/o Falcon Investment Advisors, LLC
 450 Park Avenue, Suite 1001
 New York, NY 10022
 Attn: John S. Schnabel
 Facsimile No: (212) 300-0299
	  	12,714.3	  	—  	  	$	12,714,285.71	  	$	12,714,285.71	  	—  
						
	 Falcon Mezzanine Partners II, LP
 c/o Falcon Investment Advisors, LLC
 450 Park Avenue, Suite 1001
 New York, NY 10022
 Attn: John S. Schnabel
 Facsimile No: (212) 300-0299
	  	2,268.6	  	—  	  	$	2,268,571.43	  	$	2,268,571.43	  	—  

													
						
	 FMP II Co-Investment, LLC
 c/o Falcon Investment Advisors, LLC
 450 Park Avenue, Suite 1001
 New York, NY 10022
 Attn: John S. Schnabel
 Facsimile No: (212) 300-0299
	 	17.1	  	—  	  	$	17,142.86	  	$	17,142.86	  	—  
						
	 Camden Partners Strategic Fund IV, L.P.
 c/o Camden Partners
 500 East Pratt Street, Suite 1200
 Baltimore, MD 21202
	 	—  	  	9,533	  	$	9,533,000	  	$	9,533,000	  	—  
						
	 Camden Partners Strategic Fund IV-A, L.P.
 c/o Camden Partners
 500 East Pratt Street, Suite 1200
 Baltimore, MD 21202
	 	—  	  	467	  	$	467,000	  	$	467,000	  	—Description of Non-employee Director Compensation Policy

 Exhibit 10.15 
 Description of Non-Employee Director Compensation Policy, as amended as of February 15, 2010 
 Beginning January 1, 2010, non-employee members of the Board of Directors (the “Board”) of OraSure Technologies, Inc. (the
“Company”) will receive fixed annual fees for service as a member or Chairman of the Board and for service on Committees of the Board, as set forth below. The fees shall be payable quarterly in arrears. 
  

				
	 Position
	  	Annual Fee
	 Board Member
	  	$	40,000
	 Board Chairman
	  	$	20,000
	 Audit Chairman
	  	$	18,000
	 Compensation Chairman
	  	$	15,000
	 N&CG Chairman
	  	$	8,000
	 Non-Chairman Audit Member
	  	$	8,000
	 Non-Chairman Compensation Member
	  	$	6,000
	 Non-Chairman N&CG Member
	  	$	4,000

 Each non-employee
Director receives an annual grant of 15,000 restricted shares (the “Annual Grant”) on the annual equity grant date for officers and other employees of the Company, except for the Chairman of the Board, who receives an Annual Grant of
25,000 restricted shares. 
 Annual Grants generally vest twelve (12) months after the date of grant Restricted shares
granted to non-employee Directors will also vest immediately upon the occurrence of a change in control of the Company. A change in control of the Company would occur on the happening of such events as the acquisition of beneficial ownership by a
person or group of 30 percent or more of the outstanding Common Stock of the Company, certain changes in Board membership affecting a majority of positions, certain mergers or consolidations, a sale or other transfer of all or substantially all the
Company’s assets, or approval by the stockholders of a plan of liquidation or dissolution of the Company, as well as any change in control required to be reported under the SEC’s proxy disclosure rules. Non-employee Directors are permitted
to direct the Company to withhold restricted shares in order to pay tax withholding obligations arising upon the vesting of such shares.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}]]